Gentian Violet Treatment for Hidradenitis Suppurativa

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · May 11, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how a treatment called gentian violet affects people with a skin condition known as Hidradenitis Suppurativa (HS), which causes painful lumps and sores. The researchers want to understand how patients respond to this treatment by collecting information through surveys and observing changes in the skin's condition after treatment.

To participate in this trial, you need to have active HS and be willing to have one treatment application of gentian violet, followed by a follow-up appointment in one month. Unfortunately, children and individuals without visible HS lesions during the clinic visit won't be able to join. If you do participate, you can expect to share your experiences and feelings about the treatment through surveys, which will help researchers learn more about how gentian violet might help others with this condition in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients must have active HS, be willing to undergo one application of HS, and agree to follow-up in one month.
• Exclusion Criteria:
• • Exclusion criteria include children, absent HS lesions at the time of clinic, and cognitive/physical impairments that would make them unable to assess quality of life factors of the survey.